Andreas Baumbach

2 months ago | jacc.org | Kush Patel |Andreas Baumbach

IntroductionStrokes are often the most feared complication for patients undergoing transcatheter aortic valve replacement (TAVR). They are associated with increased mortality and morbidity, impose significant challenges for family and caregivers, and weigh heavily on healthcare systems. Multiple trials have evaluated the safety and efficacy of cerebral embolic protection devices (CEPDs) and anticoagulation regimes to reduce the incidence of TAVR-related stroke.

Nov 29, 2024 | pcronline.com | Andreas Baumbach |Fernando Alfonso |Azeem Latib

Participate in this live event Register with your My PCR account, add it to your calendar and receive automatic reminders.

Apr 1, 2023 | heart.bmj.com | Andreas Baumbach |Kush Patel

http://orcid.org/0000-0002-3433-8128Kush P Patel1,2, http://orcid.org/0000-0001-7707-2254Andreas Baumbach2,3 1 Structural Heart Intervention Department, Barts Heart Centre, London, UK 2 Barts Heart Centre, Barts Health NHS Trust, London, UK 3 Cardiology, Queen Mary University of London, London, UK Correspondence to Professor Andreas Baumbach, Cardiology, Queen Mary University of London, London, UK; [email protected] Statistics from Altmetric.com Request Permissions If you wish to reuse...

Mar 10, 2023 | heart.bmj.com | Kush Patel |Andreas Baumbach

http://orcid.org/0000-0002-3433-8128Kush P Patel1,2, http://orcid.org/0000-0001-7707-2254Andreas Baumbach2,3 1 Structural Heart Intervention Department, Barts Heart Centre, London, UK 2 Barts Heart Centre, Barts Health NHS Trust, London, UK 3 Cardiology, Queen Mary University of London, London, UK Correspondence to Professor Andreas Baumbach, Cardiology, Queen Mary University of London, London, UK; a.baumbach{at}qmul.ac.uk Statistics from Altmetric.com Request Permissions If you wish to reuse...